A Novel Three-Stage AI-Assisted Approach for Accurate Differential Diagnosis and Classification of NIFTP and Thyroid Neoplasms.

IF 11.3 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Shweta Birla, Nimisha Tiwari, Pragati Shyamal, Abhishek Khatri, Divya Bandaru, Arundhati Sharma, Dinesh Gupta, Shipra Agarwal
{"title":"A Novel Three-Stage AI-Assisted Approach for Accurate Differential Diagnosis and Classification of NIFTP and Thyroid Neoplasms.","authors":"Shweta Birla, Nimisha Tiwari, Pragati Shyamal, Abhishek Khatri, Divya Bandaru, Arundhati Sharma, Dinesh Gupta, Shipra Agarwal","doi":"10.1007/s12022-025-09865-0","DOIUrl":null,"url":null,"abstract":"<p><p>The recent introduction of the term non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) marked a pivotal shift in the classification of encapsulated follicular variant of papillary thyroid carcinoma (EFVPTC) lacking invasive features. While its reclassification from the \"malignant\" to \"low-risk neoplasm\" category significantly reduced overtreatment, its histopathological diagnosis remains challenging due to overlapping features with other thyroid lesions and inter-observer variability. Artificial intelligence (AI) overcomes such key limitations of histopathological evaluation, ensuring a robust and efficient diagnostic process. While preliminary studies are promising, AI models capable of efficiently distinguishing NIFTP from other benign and malignant thyroid entities are yet to be developed. We devised an innovative AI-based three-stage hierarchical pipeline that systematically evaluates architectural patterns and nuclear features. The prioritized models were trained using 154,498 patches, derived from 134 sections prepared from 125 thyroid nodules, representing follicular nodular disease (FND), follicular adenoma, dominant nodule in FND, invasive EFVPTC (IEFVPTC), and classic and infiltrative follicular subtypes of PTC. External validation revealed good accuracy at the overall, patient-wise, and class-wise levels. However, it showed limitations in the differential diagnosis of NIFTP from IEFVPTC-an expected challenge due to overlapping nuclear features and the absence of incorporating the assessment of the tumor capsule for invasive characteristics. While the novel approach and the algorithm show promise in transforming histopathological NIFTP diagnostics, further improvements and rigorous validations are necessary before considering its application in real-world clinical settings.</p>","PeriodicalId":55167,"journal":{"name":"Endocrine Pathology","volume":"36 1","pages":"22"},"PeriodicalIF":11.3000,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine Pathology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12022-025-09865-0","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

The recent introduction of the term non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) marked a pivotal shift in the classification of encapsulated follicular variant of papillary thyroid carcinoma (EFVPTC) lacking invasive features. While its reclassification from the "malignant" to "low-risk neoplasm" category significantly reduced overtreatment, its histopathological diagnosis remains challenging due to overlapping features with other thyroid lesions and inter-observer variability. Artificial intelligence (AI) overcomes such key limitations of histopathological evaluation, ensuring a robust and efficient diagnostic process. While preliminary studies are promising, AI models capable of efficiently distinguishing NIFTP from other benign and malignant thyroid entities are yet to be developed. We devised an innovative AI-based three-stage hierarchical pipeline that systematically evaluates architectural patterns and nuclear features. The prioritized models were trained using 154,498 patches, derived from 134 sections prepared from 125 thyroid nodules, representing follicular nodular disease (FND), follicular adenoma, dominant nodule in FND, invasive EFVPTC (IEFVPTC), and classic and infiltrative follicular subtypes of PTC. External validation revealed good accuracy at the overall, patient-wise, and class-wise levels. However, it showed limitations in the differential diagnosis of NIFTP from IEFVPTC-an expected challenge due to overlapping nuclear features and the absence of incorporating the assessment of the tumor capsule for invasive characteristics. While the novel approach and the algorithm show promise in transforming histopathological NIFTP diagnostics, further improvements and rigorous validations are necessary before considering its application in real-world clinical settings.

一种新的三阶段人工智能辅助方法用于NIFTP和甲状腺肿瘤的准确鉴别诊断和分类。
最近引入的具有乳头状样核特征的非侵袭性滤泡性甲状腺肿瘤(NIFTP)一词标志着缺乏侵袭性特征的甲状腺乳头状癌(EFVPTC)的囊化滤泡变异型分类的关键转变。虽然将其从“恶性”分类为“低风险肿瘤”类别显著减少了过度治疗,但由于与其他甲状腺病变的重叠特征和观察者之间的差异,其组织病理学诊断仍然具有挑战性。人工智能(AI)克服了组织病理学评估的这些关键限制,确保了一个强大而有效的诊断过程。虽然初步研究很有希望,但能够有效区分NIFTP与其他良性和恶性甲状腺实体的人工智能模型尚未开发。我们设计了一个创新的基于人工智能的三阶段分层管道,系统地评估建筑模式和核特征。优先模型使用来自125个甲状腺结节的134个切片的154,498个斑块进行训练,分别代表滤泡性结节病(FND)、滤泡性腺瘤、FND中的显性结节、侵袭性EFVPTC (IEFVPTC)以及PTC的经典和浸润性滤泡亚型。外部验证显示在总体、患者和分类水平上具有良好的准确性。然而,它显示了与iefvptc鉴别诊断NIFTP的局限性,这是一个预期的挑战,因为重叠的核特征和缺乏对肿瘤包膜侵袭性特征的评估。虽然这种新方法和算法有望改变组织病理学NIFTP诊断,但在考虑将其应用于实际临床环境之前,还需要进一步的改进和严格的验证。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Endocrine Pathology
Endocrine Pathology 医学-病理学
CiteScore
12.30
自引率
20.50%
发文量
41
审稿时长
>12 weeks
期刊介绍: Endocrine Pathology publishes original articles on clinical and basic aspects of endocrine disorders. Work with animals or in vitro techniques is acceptable if it is relevant to human normal or abnormal endocrinology. Manuscripts will be considered for publication in the form of original articles, case reports, clinical case presentations, reviews, and descriptions of techniques. Submission of a paper implies that it reports unpublished work, except in abstract form, and is not being submitted simultaneously to another publication. Accepted manuscripts become the sole property of Endocrine Pathology and may not be published elsewhere without written consent from the publisher. All articles are subject to review by experienced referees. The Editors and Editorial Board judge manuscripts suitable for publication, and decisions by the Editors are final.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信